{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T23:07:02Z","timestamp":1764976022550,"version":"3.46.0"},"reference-count":7,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol"],"published-print":{"date-parts":[[2000,7,1]]},"DOI":"10.1001\/archderm.136.7.940","type":"journal-article","created":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T13:45:19Z","timestamp":1078148719000},"page":"940","source":"Crossref","is-referenced-by-count":12,"title":["Onychomycosis Treated Until the Nail Is Replaced by Normal Growth or There Is Failure"],"prefix":"10.1001","volume":"136","author":[{"given":"Nardo","family":"Zaias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerbert","family":"Rebell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"key":"REF-DLT0700-9-1-1","doi-asserted-by":"crossref","unstructured":"MBrautigamTerbinafine versus itraconazole: a controlled clinical comparison in onychomycosis of the toenails.J Am Acad Dermatol.199838(suppl 5, pt 3)S53S56","DOI":"10.1016\/S0190-9622(98)70485-2"},{"key":"REF-DLT0700-9-1-2","doi-asserted-by":"crossref","unstructured":"MDe BackerCDe VroeyELesaffreIScheysPDe KeyserTwelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg\/day versus itraconazole 200 mg\/day.J Am Acad Dermatol.199838(suppl 5, pt 3)S57S63","DOI":"10.1016\/S0190-9622(98)70486-4"},{"key":"REF-DLT0700-9-1-3","unstructured":"PDe DonckerJDecroixGEPierardAntifungal pulse therapy for onychomycosis: a pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole.Arch Dermatol.19961323441"},{"key":"REF-DLT0700-9-1-4","unstructured":"LDrakeNHShearJPArletteOral terbinafine in the treatment of toenail onychomycosis: North American multicenter study.J Am Acad Dermatol.199737740745"},{"key":"REF-DLT0700-9-1-5","unstructured":"GEvansRBillsteinLION Study, Novartis Pharmaceuticals Corporation, 59 Route 10, East Hanover, NJ 07936.No data available at time of publication"},{"key":"REF-DLT0700-9-1-6","unstructured":"EEpsteinHow often does oral treatment of nail onychomycosis produce a disease-free nail.Arch Dermatol.100813415511554"},{"key":"REF-DLT0700-9-1-7","unstructured":"BEElewskiA full \"cure\" for onychomycosis is not always possible.Arch Dermatol.1999135832833"}],"container-title":["Archives of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/190381\/dlt0700.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T23:02:33Z","timestamp":1764975753000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/190381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7,1]]},"references-count":7,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2000,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/archderm.136.7.940","relation":{},"ISSN":["0003-987X"],"issn-type":[{"type":"print","value":"0003-987X"}],"subject":[],"published":{"date-parts":[[2000,7,1]]}}}